Park MK, Lee YB, Moon H, Choi NR, et al. Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation. Dig Dis Sci 2022 Jan 20. pii: 10.1007/s10620-021-07365.
PMID: 35048224